The Latest From Zephyr AI

Zephyr AI Names Lisa Eli Chief Scientific Officer to Expand Precision Oncology Strategy

Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights

Zephyr AI Appoints Watson Pharmaceuticals Founder Dr. Allen Chao as Chief Executive Officer

Zephyr AI Appoints Watson Pharmaceuticals Founder Dr. Allen Chao as Chief Executive Officer

Zephyr AI Presents the Development of a Novel AI-Enabled Composite Biomarker Effective in Predicting Sensitivity to PARP Inhibition in Late-line Cancer Patients

McLean AI health care startup raises $111 million

Zephyr AI Announces the Appointment of John Applegate as its CFO

Generative AI Finds Its Footing in Drug Development

Zephyr AI Raises $111M in Series A Financing Round

Zephyr AI Raises $111 Million in Series A Financing

Zephyr AI closes $111M series A funding round

Have a media inquiry?